Gary Hattersley
About Gary Hattersley
Gary Hattersley Chief Scientific Officer at Nuvation Bio
Gary Hattersley has been serving as the Chief Scientific Officer at Nuvation Bio since 2019. His position at Nuvation Bio leverages his extensive background in scientific research and development, particularly in the fields of oncology and women’s health. As Chief Scientific Officer, Hattersley plays a central role in guiding the scientific directions and therapeutic developments of the company, contributing his expertise to the advancement of biological innovations.
Gary Hattersley's Career at Radius Health Inc.
Before joining Nuvation Bio, Gary Hattersley spent 15 years at Radius Health Inc., where he supported the development of an extensive oncology and women’s health portfolio. During his tenure, he advanced through roles of increasing seniority, including positions as Chief Scientific Officer, Senior Vice President of Preclinical Development, and Vice President of Biology. His work significantly contributed to Radius Health's progress in bringing innovative health solutions to the market.
Gary Hattersley's Role at Millennium Pharmaceuticals
Prior to his time at Radius Health, Gary Hattersley worked as a Senior Scientist at Millennium Pharmaceuticals. In this role, he was responsible for the discovery and development of novel small molecule agents aimed at treating metabolic bone diseases. His contributions at Millennium Pharmaceuticals involved crucial advancements in therapeutic research and underscored his capability in managing complex scientific projects.
Gary Hattersley's Early Career at Genetics Institute
Gary Hattersley began his scientific career at Genetics Institute, where he explored the application of bone morphogenetic proteins in musculoskeletal disease. His work at Genetics Institute provided a strong foundation for his ensuing contributions to medical science, particularly in the context of bone biology and musculoskeletal therapeutics.
Gary Hattersley's Education
Gary Hattersley received his Ph.D. from St. George’s Hospital Medical School in London. His academic training laid the groundwork for his later work in the biotechnology and pharmaceutical sectors, equipping him with the knowledge and skills necessary for his roles in scientific research and development.